Dose adaptation of the drugs used for ...
Document type :
Article dans une revue scientifique
PMID :
Permalink :
Title :
Dose adaptation of the drugs used for hematopoietic stem-cell transplantation in patients with comorbidity: Obesity, chronic renal disease or hepatopathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Author(s) :
Simon, Nicolas [Auteur]
Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 [GRITA]
Coiteux, Valerie [Auteur]
Bruno, Benedicte [Auteur]
Taque, Sophie [Auteur]
Charbonnier, Amandine [Auteur]
Souchet, Laetitia [Auteur]
Vincent, Laure [Auteur]
Yakoub-Agha, Ibrahim [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Chalandon, Yves [Auteur]
Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 [GRITA]
Coiteux, Valerie [Auteur]
Bruno, Benedicte [Auteur]
Taque, Sophie [Auteur]
Charbonnier, Amandine [Auteur]
Souchet, Laetitia [Auteur]
Vincent, Laure [Auteur]
Yakoub-Agha, Ibrahim [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Chalandon, Yves [Auteur]
Journal title :
Bulletin du cancer
Abbreviated title :
Bull. Cancer
Volume number :
104
Pages :
S99-S105
Publication date :
2017
HAL domain(s) :
Sciences du Vivant [q-bio]
French abstract :
In September 2016 in Lille, France, the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) organized the 7th Allogeneic Stem Cell Transplantation Clinical Practices Harmonization Workshop ...
Show more >In September 2016 in Lille, France, the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) organized the 7th Allogeneic Stem Cell Transplantation Clinical Practices Harmonization Workshop Series. Our work group focused on chemotherapy drug dose adaptation for hematopoietic stem cell transplantation patients presenting a comorbidity. The purpose of this workshop was to provide recommendations on chemotherapy drug dose adaptation for patient populations receiving hematopoietic stem cell transplantation who also had the following comorbidities: obesity, chronic kidney disease and hepatopathy.Show less >
Show more >In September 2016 in Lille, France, the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) organized the 7th Allogeneic Stem Cell Transplantation Clinical Practices Harmonization Workshop Series. Our work group focused on chemotherapy drug dose adaptation for hematopoietic stem cell transplantation patients presenting a comorbidity. The purpose of this workshop was to provide recommendations on chemotherapy drug dose adaptation for patient populations receiving hematopoietic stem cell transplantation who also had the following comorbidities: obesity, chronic kidney disease and hepatopathy.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Université de Lille
CHU Lille
Inserm
CHU Lille
Inserm
Collections :
Research team(s) :
Innovation/évaluation des dispositifs médicaux de perfusion
Submission date :
2019-02-26T17:15:44Z